320 related articles for article (PubMed ID: 30602354)
21. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.
Roaldsen MB; Eltoft A; Wilsgaard T; Christensen H; Engelter ST; Indredavik B; Jatužis D; Karelis G; Kõrv J; Lundström E; Petersson J; Putaala J; Søyland MH; Tveiten A; Bivard A; Johnsen SH; Mazya MV; Werring DJ; Wu TY; De Marchis GM; Robinson TG; Mathiesen EB;
Lancet Neurol; 2023 Feb; 22(2):117-126. PubMed ID: 36549308
[TBL] [Abstract][Full Text] [Related]
22. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
[TBL] [Abstract][Full Text] [Related]
23. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.
Wang Y; Li S; Pan Y; Li H; Parsons MW; Campbell BCV; Schwamm LH; Fisher M; Che F; Dai H; Li D; Li R; Wang J; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X;
Lancet; 2023 Feb; 401(10377):645-654. PubMed ID: 36774935
[TBL] [Abstract][Full Text] [Related]
24. Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection.
Albers GW; Jumaa M; Purdon B; Zaidi SF; Streib C; Shuaib A; Sangha N; Kim M; Froehler MT; Schwartz NE; Clark WM; Kircher CE; Yang M; Massaro L; Lu XY; Rippon GA; Broderick JP; Butcher K; Lansberg MG; Liebeskind DS; Nouh A; Schwamm LH; Campbell BCV;
N Engl J Med; 2024 Feb; 390(8):701-711. PubMed ID: 38329148
[TBL] [Abstract][Full Text] [Related]
25. Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke.
Huang X; Moreton FC; Kalladka D; Cheripelli BK; MacIsaac R; Tait RC; Muir KW
Stroke; 2015 Dec; 46(12):3543-6. PubMed ID: 26514192
[TBL] [Abstract][Full Text] [Related]
26. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
[TBL] [Abstract][Full Text] [Related]
27. Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase.
Kim DJ; Singh N; Catanese L; Yu AYX; Demchuk AM; Lloret-Villas MI; Deschaintre Y; Coutts SB; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Manosalva H; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Phillips S; Hill MD; Poppe AY; Ademola A; Shamy M; Bala F; Sajobi TT; Swartz RH; Almekhlafi MA; Menon BK; Field TS
Stroke; 2024 Feb; 55(2):288-295. PubMed ID: 38174568
[TBL] [Abstract][Full Text] [Related]
28. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
Hacke W; Kaste M; Bluhmki E; Brozman M; Dávalos A; Guidetti D; Larrue V; Lees KR; Medeghri Z; Machnig T; Schneider D; von Kummer R; Wahlgren N; Toni D;
N Engl J Med; 2008 Sep; 359(13):1317-29. PubMed ID: 18815396
[TBL] [Abstract][Full Text] [Related]
29. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.
Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K
Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903
[TBL] [Abstract][Full Text] [Related]
30. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
[TBL] [Abstract][Full Text] [Related]
31. Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.
Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Zhao H; Alemseged F; Ng F; Bailey P; Rice H; de Villiers L; Dewey HM; Choi PMC; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Kraemer T; Krause M; Cordato D; Field D; Ma H; O'Brien B; Clissold B; Miteff F; Clissold A; Cloud GC; Bolitho LE; Bonavia L; Bhattacharya A; Wright A; Mamun A; O'Rourke F; Worthington J; Wong AA; Levi CR; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
JAMA; 2020 Apr; 323(13):1257-1265. PubMed ID: 32078683
[TBL] [Abstract][Full Text] [Related]
32. Safety and predictors of stroke mimics in The Norwegian Tenecteplase Stroke Trial (NOR-TEST).
Kvistad CE; Novotny V; Næss H; Hagberg G; Ihle-Hansen H; Waje-Andreassen U; Thomassen L; Logallo N
Int J Stroke; 2019 Jul; 14(5):508-516. PubMed ID: 30019629
[TBL] [Abstract][Full Text] [Related]
33. Tenecteplase in ischemic stroke offers improved recanalization: Analysis of 2 trials.
Bivard A; Huang X; Levi CR; Spratt N; Campbell BCV; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
Neurology; 2017 Jul; 89(1):62-67. PubMed ID: 28576782
[TBL] [Abstract][Full Text] [Related]
34. Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase.
Chester KW; Corrigan M; Schoeffler JM; Shah M; Toy F; Purdon B; Dillon GM
Expert Opin Drug Saf; 2019 Feb; 18(2):87-96. PubMed ID: 30712409
[TBL] [Abstract][Full Text] [Related]
35. Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core.
Gerschenfeld G; Turc G; Obadia M; Chausson N; Consoli A; Olindo S; Caroff J; Marnat G; Blanc R; Ben Hassen W; Seners P; Guillon B; Wiener E; Bourcier R; Yger M; Cho TH; Checkouri T; Gory B; Smadja D; Sibon I; Richard S; Piotin M; Eker OF; Pico F; Lapergue B; Alamowitch S;
Neurology; 2024 Jul; 103(1):e209398. PubMed ID: 38862134
[TBL] [Abstract][Full Text] [Related]
36. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
37. Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke.
Walton MN; Hamilton LA; Salyer S; Wiseman BF; Forster AM; Rowe AS
Ann Pharmacother; 2023 May; 57(5):535-543. PubMed ID: 36004394
[TBL] [Abstract][Full Text] [Related]
38. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
[TBL] [Abstract][Full Text] [Related]
39. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
[TBL] [Abstract][Full Text] [Related]
40. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.
Burgos AM; Saver JL
Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
